The Latest Cardiac and Vascular News
MINNEAPOLIS, March 5, 2025 /PRNewswire/ — 4C Medical Technologies, Inc. (“4C Medical”), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, today announced the closing of its Series D financing round resulting in gross proceeds of up to $175 million, led by Boston Scientific Corporation, with participation from […]
BEDFORD, Mass., Aug. 28, 2017 /PRNewswire/ — Access Vascular, a medical device company developing innovative venous access devices that eliminate thrombotic risk, today announced $3.7 million in funding from individual investors and angelMD, an investment platform and marketplace connecting innovative medical startups, physicians, investors and industry partners. This financing will help support submission of […]
CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation Proceeds to Support Company Growth, Ongoing Clinical Trial Enrollment and New Product Initiatives CeloNova BioSciences, Inc. (CeloNova), a medical device company that develops, manufactures and markets a family of innovative cardiovascular products based upon its novel Polyzene™-F […]
Tuebingen, 27. July 2017. SHS Gesellschaft für Beteiligungsmanagement is investing in CoreMedic, a start-up developing innovative, transfemoral repair systems to treat heart valve malfunctions. SHS is investing from its fourth fund generation to finance CoreMedic’s further growth and the clinical application of its innovative products. Mitral heart valve regurgitation (MR) […]
QT Vascular Secures Up To S$20 Million Capital Commitment GEM Global SINGAPORE, March 21, 2017 /PRNewswire/ — QT Vascular Ltd., (the “Company” or “QT Vascular“, and together with its subsidiaries, the “Group“) announced that it has signed an agreement (“Agreement“) with GEM Global Yield Fund LLC SCS (“GEM Global“), the New York based […]
